Identification of 3-aminothieno[2,3-b]pyridine-2-carboxamides and 4-aminobenzothieno[3,2-d]pyrimidines as LIMK1 inhibitors
- Sleebs, BE; Levit, A; Street, IP; Falk, H; Hammonds, T; Wong, AC; Charles, MD; Olson, MF; Baell, JB;
Publication Year 2011-10, Volume 2, Issue #10, Page 977-981
- Journal Title
- Publication Type
- Journal Article
- A high throughput chemical screening campaign has led to the identification of 3-aminobenzo[b]thiophene-2-carboxamides as LIMK I inhibitors. Evolution of bicyclic hits to the tricyclic 4-aminobenzothieno[3,2-d]pyrimidine, using a traditional medicinal chemistry SAR guided approach, resulted in a significant increase in potency. Further elaboration has seen the 7-phenyl-4-aminobenzothieno[3,2-d]pyrimidine emerge as a LIMK I inhibitor lead candidate.
- ROYAL SOC CHEMISTRY
- ACTIN DYNAMICS; KINASE
- Publisher's Version
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2011-10-01 12:00:00Last Modified: 0001-01-01 12:00:00